Search results for “Lymphocytopoiesis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 60 patents, we discovered top 28 key players by total patent application. Novartis AG, Jiangsu Quanxin Biomedical Co Ltd, MedImmune LLC are dominant in this area. They take 30.00% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 6
MedImmune LLC
Louisiana, United States
Patent: 2
Immunex Corp.
Washington, United States
Patent: 2
Istituto Europeo di Oncologia SRL
Lombardia, Italy
Patent: 2
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 2
Intervet International BV
Noord-Brabant, Netherlands
Patent: 2
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 2
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 2
Shanghai Mabgeek Biotechnology Co Ltd
Shanghai Shi, China
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 31 patents applied in the last 5 years. We discover 26 most active companies in this area. The fast-growing Jiangsu Quanxin Biomedical Co Ltd, Novartis AG, MedImmune LLC take 35.48% of patent filing during this period.
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 6
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
MedImmune LLC
Louisiana, United States
Patent: 2
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 2
Beijing Huizhiheyuan Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 2
Beijing Zhiren Meibo Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
Shanghai Mabgeek Biotechnology Co Ltd
Shanghai Shi, China
Patent: 2
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 2
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 31 patents in last 5 years, we discover 23 new entrants. Jiangsu Quanxin Biomedical Co Ltd, MedImmune Ltd., MedImmune LLC are the most active new entrants in this area.
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 6
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 2
MedImmune LLC
Louisiana, United States
Patent: 2
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 2
Beijing Huizhiheyuan Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
Beijing Zhiren Meibo Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
Shanghai Mabgeek Biotechnology Co Ltd
Shanghai Shi, China
Patent: 2
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 2
Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Shi, China
Patent: 1
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 7 patents, we discovered top 4 universities and scientific research institutions by total patent application. University of Washington, Washington University in St. Louis, Albert Einstein College of Medicine, Inc. are dominant in this area. They take 57.14% of the total patent filing.
University of Washington
Washington, United States
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 1
Universite Paris Est Creteil Val De Marne
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: